title: Effects of CYP4F2 and GGCX genetic variants on maintenance warfarin dose in a multi-ethnic Asian population.
authors.forename: S L
authors.initials: SL
authors.lastname: Chan
authors.forename: B C
authors.initials: BC
authors.lastname: Goh
authors.forename: K S
authors.initials: KS
authors.lastname: Chia
authors.forename: B
authors.initials: B
authors.lastname: Chuah
authors.forename: A
authors.initials: A
authors.lastname: Wong
authors.forename: R
authors.initials: R
authors.lastname: Lim
authors.forename: S C
authors.initials: SC
authors.lastname: Lee
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D054316:Biomarkers, Pharmacological / Q000378:metabolism; D019735:Carbon-Carbon Ligases / Q000235:genetics / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism*; D000072470:Cytochrome P450 Family 4; D004252:DNA Mutational Analysis; D054796:Drug Dosage Calculations; D005006:Ethnicity; D005787:Gene Frequency; D056726:Genetic Association Studies; D005838:Genotype; D006801:Humans; D018895:Microsatellite Repeats / Q000235:genetics; D009154:Mutation / Q000235:genetics; D011110:Polymorphism, Genetic; D015983:Selection Bias; D012846:Singapore; D013923:Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000235:genetics; D014859:Warfarin / Q000008:administration & dosage
chemical_list: D000925:Anticoagulants; D054316:Biomarkers, Pharmacological; D014859:Warfarin; D003577:Cytochrome P-450 Enzyme System; D000072470:Cytochrome P450 Family 4; C117480:CYP4F2 protein, human; D019735:Carbon-Carbon Ligases; C020660:glutamyl carboxylase